Manual for Acute Lymphoblastic Leukemia (cll)

The slow-growing leukemia known as chronic lymphocytic leukemia (CLL) attacks nascent B cells. White blood cells called B lymphocytes (or B-cells) have a specific function. Immunoglobulins, commonly known as antibodies, are produced under typical circumstances and aid in warding off illness and infection. Lymphocytes become leukaemic cells after undergoing a malignant (cancerous) transformation in persons with CLL. It's crucial to stress that many patients with CLL...
More Description

The slow-growing leukemia known as chronic lymphocytic leukemia (CLL) attacks nascent B cells. White blood cells called B lymphocytes (or B-cells) have a specific function. Immunoglobulins, commonly known as antibodies, are produced under typical circumstances and aid in warding off illness and infection. Lymphocytes become leukaemic cells after undergoing a malignant (cancerous) transformation in persons with CLL.

It's crucial to stress that many patients with CLL experience no progression of their disease for months or even years. About 30-50% of those who are diagnosed with CLL never need treatment for their condition and may live for many years anyway. Those affected by leukemia have abnormal white blood cells (leukocytes) that proliferate uncontrollably, survive for longer than they should, and build up in organs such the bone marrow, blood, lymph nodes (glands), spleen, and liver. Because of their abnormality, these cells cannot function normally. A buildup of lymphocytes in the bone marrow disrupts regular blood cell generation.